Evidence map›Paper›PMID 41963418›Full record

ArticleScientific reports2026

Optimization of urban freight intelligent route based on reinforcement learning.

Guizhe Xin, Yuqing Tang, Hongzhen Gao, Na Li

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Guizhe XinCollege of Architecture and Urban Planning, Tongji University, Shanghai, 200092, China.
Yuqing TangCollege of Architecture and Urban Planning, Tongji University, Shanghai, 200092, China. yuqingtang18@outlook.com.
Hongzhen GaoInstitute of Transportation Research, Qingdao Urban Planning and Design Research Institute, Qingdao, 266071, Shandong, China.
Na LiDepartment of Industrial Planning and Consulting, Qingdao Engineering Consulting Institute, Qingdao, 266035, Shandong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Increased traffic congestion, limited delivery windows, vehicles' diverse fleets, and dynamic environments are all contributing factors to the inefficiency of urban freight systems. Due to the inability of traditional routing techniques to adjust in real-time to partially visible multi-constrained conditions, delivery delays, fuel consumption, and operating costs all increased. This research proposes a constraint-aware projected policy learning-reinforcement learning (CAPPL-RL) framework to optimize urban freight delivery routes while enforcing real-world constraints, including traffic congestion, delivery time windows, and vehicle capacity. The routing problem is formulated as a partially observable Markov decision process, with autonomous vehicles as agents navigating stochastic urban traffic networks. Using the UFVOD dataset, CAPPL-RL integrates Q-learning with ε-greedy exploration and projection-based constrained policy optimization (PCPO) to enable adaptive, constraint-aware routing. Simulation results demonstrate that CAPPL-RL outperforms PCPO-RL, reducing average delivery time from 65.3 to 52.1 min (20.2%), fuel consumption from 0.12 to 0.093 L/km (22.5%), and constraint violations in time windows from 12 to 3 (75%) while achieving 100% compliance with vehicle capacity limits. These results validate CAPPL-RL as a robust, scalable, and adaptive framework for dynamic urban freight logistics.

Indexed as

Constraint-aware routingDynamic delivery optimizationPartially observable Markov decision process (PO-MDP)Reinforcement learning (RL)Traffic-aware logisticsUrban freight optimization

Identifiers

PMID41963418
PMCPMC13230551

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.